Johnson & Johnson will take steps to get shareholder lawsuits brought against its management and directors dismissed and create a board committee to oversee the health care product maker's quality compliance issues.
Swiss drug maker Novartis AG saw net profits rise 12 percent to $2.73 billion in the second quarter amid strong sales of new products and healthy growth in emerging markets such as China.
Nabi Biopharmaceuticals said that its anti-smoking vaccine NicVAX did not meet its main trial goal. The company said that patients who received a dummy shot were able to quit smoking at a similar rate to patients who were treated with NicVAX.
Researchers at the University of Pennsylvania’s School of Veterinary Medicine have shown for the first time that dogs that develop Activated B-Cell Diffuse Large B-Cell Lymphoma (ABC-DLBCL) share the same aberrant activation of a critical intracellular pathway with humans.
SEEK has completed a Phase Ib/II clinical trial of its HIV-v vaccine which demonstrates a one log (approximately 90%) difference in viral count in HIV-infected people compared with the placebo group, after just a single vaccine injection.
LEO Pharma A/S and The Scripps Research Institute have entered a research collaboration.
Knome announced that its services aided in the discovery of a mutation associated with an inherited form of Parkinson’s disease (PD).
Seattle Genetics, Inc. announced that the Oncologic Drugs Advisory Committee (ODAC) to the Food and Drug Administration (FDA) voted 10-0 to recommend that the FDA grant accelerated approval of Adcetris (brentuximab vedotin) for the treatment of patients with Hodgkin lymphoma who relapse after autologous stem cell transplant (ASCT).
GlaxoSmithKline (GSK) and Human Genome Sciences, Inc. announced the European Commission (EC) has granted marketing authorization for Benlysta (belimumab) 10mg/kg as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus (SLE), with a high degree of disease activity despite standard therapy.
Researchers at New York University’s Department of Chemistry and NYU Langone Medical Center have developed a compound that blocks signaling from a protein implicated in many types of cancer.
Corning Incorporated announced the Corning LSE compact centrifuge for use in a variety of clinical applications, including sedimentation of urine and blood samples.
Kimble Chase, the world's largest manufacturer of laboratory glassware products, has released its heavy-duty KIMAX borosilicate glassware, which offers maximum mechanical strength and thermal shock resistance.
Vince & Associates Clinical Research, a provider of early development clinical trials to the biopharmaceutical industry announces the opening of their dedicated Neuropsychiatric Research Center.
Canadian drugmaker Valeant Pharmaceuticals International Inc. said it will buy the assets of the Ortho Dermatologics division of Janssen Pharmaceuticals Inc. for $345 million.
Kowa Pharmaceuticals and Eli Lilly released study results that investigated the potential interaction of cholesterol drug LIVALO 4 mg in healthy volunteers taking the protease inhibitor combination lopinavir/ritonavir for HIV infection.